| Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis N Ahmad, SD Ahuja, OW Akkerman, JWC Alffenaar, LF Anderson, ... The Lancet 392 (10150), 821-834, 2018 | 515 | 2018 |
| MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network GB Migliori, S Tiberi, A Zumla, E Petersen, JM Chakaya, C Wejse, ... International Journal of Infectious Diseases 92, S15-S25, 2020 | 221 | 2020 |
| Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis Z Lan, N Ahmad, P Baghaei, L Barkane, A Benedetti, SK Brode, ... The Lancet Respiratory Medicine 8 (4), 383-394, 2020 | 192 | 2020 |
| Early safety and efficacy of the combination of bedaquiline and delamanid for the treatment of patients with drug-resistant tuberculosis in Armenia, India, and South Africa: a … G Ferlazzo, E Mohr, C Laxmeshwar, C Hewison, J Hughes, S Jonckheere, ... The Lancet Infectious Diseases 18 (5), 536-544, 2018 | 149 | 2018 |
| Treatment outcomes for HIV and MDR-TB co-infected adults and children: systematic review and meta-analysis P Isaakidis, EC Casas, M Das, X Tseretopoulou, EE Ntzani, N Ford The International Journal of Tuberculosis and Lung Disease 19 (8), 969-978, 2015 | 146 | 2015 |
| Treatment and outcomes in children with multidrug-resistant tuberculosis: a systematic review and individual patient data meta-analysis EP Harausz, AJ Garcia-Prats, S Law, HS Schaaf, T Kredo, JA Seddon, ... PLoS medicine 15 (7), e1002591, 2018 | 145 | 2018 |
| Epidemiology and interaction of diabetes mellitus and tuberculosis and challenges for care: a review AD Harries, S Satyanarayana, AMV Kumar, SB Nagaraja, P Isaakidis, ... Public health action 3 (1), 3-9, 2013 | 137 | 2013 |
| Relation between burden of disease and randomised evidence in sub-Saharan Africa: survey of research P Isaakidis, GH Swingler, E Pienaar, J Volmink, JPA Ioannidis BMJ 324 (7339), 702, 2002 | 135 | 2002 |
| Adverse events among HIV/MDR-TB co-infected patients receiving antiretroviral and second line anti-TB treatment in Mumbai, India P Isaakidis, B Varghese, H Mansoor, HS Cox, J Ladomirska, P Saranchuk, ... PloS one 7 (7), e40781, 2012 | 131 | 2012 |
| ‘I cry every day’: experiences of patients co‐infected with HIV and multidrug‐resistant tuberculosis P Isaakidis, S Rangan, A Pradhan, J Ladomirska, T Reid, K Kielmann Tropical Medicine & International Health 18 (9), 1128-1133, 2013 | 115 | 2013 |
| Ambulatory multi-drug resistant tuberculosis treatment outcomes in a cohort of HIV-infected patients in a slum setting in Mumbai, India P Isaakidis, HS Cox, B Varghese, C Montaldo, E Da Silva, H Mansoor, ... PloS one 6 (12), e28066, 2011 | 104 | 2011 |
| “When Treatment Is More Challenging than the Disease”: A Qualitative Study of MDR-TB Patient Retention KS Shringarpure, P Isaakidis, KD Sagili, RK Baxi, M Das, A Daftary PloS one 11 (3), e0150849, 2016 | 100 | 2016 |
| Re-inventing adherence: toward a patient-centered model of care for drug-resistant tuberculosis and HIV MR O'Donnell, A Daftary, M Frick, Y Hirsch-Moverman, KR Amico, ... The International Journal of Tuberculosis and Lung Disease 20 (4), 430-434, 2016 | 96 | 2016 |
| Infection control for drug-resistant tuberculosis: early diagnosis and treatment is the key G Van Cutsem, P Isaakidis, J Farley, E Nardell, G Volchenkov, H Cox Clinical Infectious Diseases 62 (suppl_3), S238-S243, 2016 | 94 | 2016 |
| Resistance patterns among multidrug-resistant tuberculosis patients in greater metropolitan Mumbai: trends over time A Dalal, A Pawaskar, M Das, R Desai, P Prabhudesai, P Chhajed, ... PloS one 10 (1), e0116798, 2015 | 89 | 2015 |
| Alarming levels of drug-resistant tuberculosis in HIV-infected patients in metropolitan Mumbai, India P Isaakidis, M Das, AMV Kumar, C Peskett, M Khetarpal, A Bamne, ... PloS one 9 (10), e110461, 2014 | 84 | 2014 |
| Evaluation of cluster randomized controlled trials in sub-Saharan Africa P Isaakidis, JPA Ioannidis American Journal of Epidemiology 158 (9), 921-926, 2003 | 84 | 2003 |
| Factors associated with unfavorable treatment outcomes in new and previously treated TB patients in Uzbekistan: a five year countrywide study J Gadoev, D Asadov, M Tillashaykhov, K Tayler-Smith, P Isaakidis, ... PloS one 10 (6), e0128907, 2015 | 76 | 2015 |
| Poor outcomes in a cohort of HIV-infected adolescents undergoing treatment for multidrug-resistant tuberculosis in Mumbai, India P Isaakidis, R Paryani, S Khan, H Mansoor, M Manglani, A Valiyakath, ... PLoS One 8 (7), e68869, 2013 | 76 | 2013 |
| Combination treatment for visceral leishmaniasis patients coinfected with human immunodeficiency virus in India R Mahajan, P Das, P Isaakidis, T Sunyoto, KD Sagili, MA Lima, G Mitra, ... Clinical Infectious Diseases 61 (8), 1255-1262, 2015 | 73 | 2015 |
